Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong · Delayed Price · Currency is HKD 3.110
+0.020 (0.65%)
Oct 31, 2025, 4:08 PM HKT
Zhaoke Ophthalmology Company Description
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, Hong Kong, and internationally.
It develops various drugs that cover ophthalmic indications, including dry eye disease, myopia, presbyopia, wet age-related macular degeneration, diabetic macular edema, and glaucoma.
The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People’s Republic of China.
Zhaoke Ophthalmology Limited
| Country | Cayman Islands |
| Founded | 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 294 |
| CEO | Xiaoyi Li |
Contact Details
Address: No. 1 Meide 3rd Road Guangzhou China | |
| Phone | 86 20 3906 2828 |
| Website | zkoph.com |
Stock Details
| Ticker Symbol | 6622 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG989M51017 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Xiaoyi Li Ph.D. | Chief Executive Officer and Executive Chairman of the Board |
| Xiangrong Dai | Chief Operating Officer and Executive Director |
| Dr. Lit Fui Lau | President and Chief Scientific Officer |
| Yang Lei | Group General Counsel |
| Dr. Mauro Bove Ph.D. | Senior Vice President of Corporate Development |
| Jiang Feng | Senior Vice President of Sales and Marketing |
| Guohui Zhang | Senior Vice President of Manufacturing and Logistics |
| Carol Liu | Group Head of Regulatory Affairs |
| Suk Yan Yau CPA | Vice President of Financial Dept. and Company Secretary |